Jack Elias to transition to senior health advisor at Brown, will leave role as medical school dean

After eight years leading biology and medicine at Brown, Elias will become the University’s senior health advisor, working to realize the vision of an integrated academic health system with Lifespan and Care New England.

PROVIDENCE, R.I. [Brown University] — Dr. Jack A. Elias, dean of the Warren Alpert Medical School, has been named to a new senior position at Brown in which he will work with University leadership to advance the development of the University’s new relationship with two local health systems to create the first integrated academic health system for Rhode Island, once the merger of the two systems is approved.

After helping to transform medical education and biomedical research in his eight years at Brown, in the coming months Elias will transition to the role of senior advisor for health affairs, reporting jointly to the University president and provost. In this role, he will continue to play a key part in working with Lifespan and Care New England to implement future plans announced in February to align health system operations and Brown’s leading-edge research and renowned medical expertise to improve the quality of health care for patients across the state and region.

Plans for Elias’ transition began with conversations among Brown’s senior leadership in fall 2020. A national search for his successor will be launched in May. Until his successor is in place, Elias will continue in his current roles as dean overseeing Brown’s Division of Biology and Medicine, which encompasses the medical school, and senior vice president for health affairs.

“Jack has been a transformative leader who has shaped the Division of Biology and Medicine through his vision for translational science focused on treating disease,” Brown President Christina H. Paxson said. “Through his drive and determination, he has fueled exceptional growth in research and teaching, achieved dramatic increases in grant awards, raised the national profile of the Warren Alpert Medical School, and expanded the impact of its physician-scientists and its graduates.”

Elias has strengthened medical education, including introducing new academic programs and degrees, and bolstered Brown’s focus on evidence-based research and biomedical innovation, Paxson said. Funding for research in the division has increased more than 150% since Elias became dean; he led the development of multiple centers and programs, including the Cancer Center at Brown University established last year; built record-breaking philanthropic support; and helped the Warren Alpert Medical School climb to be ranked among the Top 10 most selective medical schools in the country.

"One of the things I talk about is the dream that the next dean will look out the window of the dean's suite at 222 Richmond and see a mass of biotech companies in the Jewelry District, all of which are making new products based on Brown, Lifespan or Care New England intellectual property, and all of them employing people and turning Rhode Island into a biotech hub."

Dr. Jack A. Elias
Elias procession

At the same time, Elias expanded Brown’s clinical practice and the University’s relationships with physician groups and affiliated health systems. This laid the foundation for the work he’ll build upon in his new position working with leaders at Care New England and Lifespan, according to Provost Richard M. Locke.

“Jack will play an essential role in furthering the relationship with the health systems to integrate medical innovation and pioneering research to inform clinical care in such areas as cancer, women’s health, and brain diseases like Alzheimer’s and ALS,” Locke said. “These are all areas where Brown has expertise and Jack has deep experience. He has provided leadership in all discussions and arrangements regarding research and teaching activities involving Brown University and its clinical faculty and current affiliated hospital partners.”

Elias is expected to advise the president and provost in enhancing of the coordination of medical education and research with clinical practice across the merged system’s hospitals.

“I am very excited to play a part in helping to do for Rhode Island what academic health systems have done for Boston, Pittsburgh and other cities across the country,” Elias said. “One of the things I talk about is the dream that the next dean will look out the window of the dean's suite at 222 Richmond and see a mass of biotech companies in the Jewelry District, all of which are making new products based on Brown, Lifespan or Care New England intellectual property, and all of them employing people and turning Rhode Island into a biotech hub.”

“There's no reason that biotech is booming in Boston and stops at the Rhode Island border,” Elias added.

A record of accomplishment

A physician-scientist specializing in immunobiology and pulmonary and critical-care medicine, Elias arrived at Brown to serve as the seventh dean in biology and medicine in September 2013. He continued to serve as dean while being appointed to the new position of senior vice president for health affairs in May 2017.

Locke said the inaugural appointment recognized the growing importance and complexity of academic medicine and health sciences at Brown, and in the state and the region.

“Jack spearheaded the development of a strategic plan that established a path of concrete actions necessary to advance the academic excellence of the Warren Alpert Medical School and biology at Brown, as well as the relationships among our campus and community stakeholders.”

In 2015, Elias formed the Brown Institute for Translational Science (BITS), establishing numerous research teams within BITS as part of a major restructuring of research areas in the medical school. These include the Brown Center for Biomedical Informatics; Center on the Biology of Aging; program in Vaccine Biology and Global Health; joint programs with Lifespan in cancer biology and the Center for Digital Health; and the Center for Translational Neuroscience with the Carney Institute for Brain Science, among others.

Elias also launched Brown Biomedical Innovations to Impact (BBII), a “proof of concept” commercialization and entrepreneurial fund that is designed to bridge the gap between federal funding for research and private investment in a product, drug or biologic. In addition, last year he oversaw the formation of Brown’s new Cancer Center dedicated to research and clinical developments. An outgrowth of the Joint Program in Cancer Biology previously established by Brown and Lifespan, the center is focusing efforts on world-class research, developing new therapeutics and addressing patients’ unique needs.

“With BBII, the Cancer Center and other programs, we have the chance to really do something significant in terms of improving patient care, integrating patient care, taking the region to the next level in terms of research and teaching, and being an economic engine,” Elias said.

Building investment in the programs in medicine and biology has been a central part of Elias’ efforts. Under his leadership, the Division of Biology and Medicine has raised more than $222 million through the BrownTogether fundraising campaign. This includes 19 endowed professorships, which give Brown the means to attract and retain the best teachers and scholars. Research funding increased from almost $37 million in Fiscal Year 2013, the year that Elias arrived at Brown, to $95 million in the most recently completed 2020 fiscal year.

Elias has worked to strengthen the medical school community through mentoring and training programs, including re-launching Brown’s M.D./Ph.D. program with a $27 million gift from the Warren Alpert Foundation. The medical school also established the Gateways to Medicine, Health Care and Research master’s program to prepare students for medical school or careers in health care. Numerous clinical and biology department chairs were recruited during Elias’ tenure, and student recruitment and retention initiatives have resulted in an increasingly diverse student body. About 25% of Brown’s medical school students now come from backgrounds that are historically underrepresented in medicine.

Fulfilling an early goal to form an academic health system

Elias said the body of his work in the Division of Medicine and Biology — and the improved strength of the academic, research and clinical program — has helped lead him to the new role he will assume as senior health advisor to the president and provost.

He had a vision for Brown becoming part of an integrated academic health system from the time he first interviewed for the deanship in Providence. He was serving as chair of internal medicine at the Yale School of Medicine and physician-in-chief at Yale New Haven Hospital at that time.

“I remember driving back from Providence to New Haven and passing a billboard advertising Boston cardiologists who were coming into Rhode Island to care for patients,” Elias said. “I remember saying to myself, ‘Why would that be? The hospitals, the physicians, the research — we could all work together to do it all locally.’ So I’ve had the dream of bringing everybody together since my first days at Brown.”

The first major step in the effort was guiding the formation of Brown Physicians, Inc. (BPI) in 2017. By bringing together the six medical practices employing about 550 physicians, BPI has enabled a new level of coordination for research, teaching and clinical care in Southern New England. Elias called it “a big step forward.”

“The clear vision that Jack Elias brings for aligning research and training with health system operations will bring tremendous benefits to Rhode Island and the region,” said Dr. James E. Fanale, president and CEO of Care New England. “The community here deserves integrated academic health system, and Jack expertly identifies the benefits of bench-to-bedside work for not only the patients, but also for the ability of our region to attract health care workers, their families, and surrounding industry and economic benefit.”

The development of an enhanced relationship with Care New England and Lifespan aims to advance biomedical discovery, educate future leaders in medicine and health care, and create a vibrant economic nexus in the state and the region based on the health care industry.

Dr. Timothy J. Babineau, Lifespan president and CEO, said Elias has been a “tremendous partner during his tenure as dean of the Warren Alpert Medical School.”

“I have enjoyed working with him immensely,” Babineau said. “His vision and energy has elevated the medical school at Brown to heights not imagined when he arrived. In addition, his strong desire and persistence to create an integrated academic health system has contributed, in large measure, to where we find ourselves today in achieving that vision. I look forward to working with Dr. Elias once the merger with Care New England is complete to bring this vision to reality.”

Elias said he looks forward to the ongoing collaboration with the leaders of the health systems. He considers it an honor to play a key role in supporting the integrated academic health system.

“I want to thank the chancellor, the president and provost for giving me the opportunity,” he said. “But most of all, I really want to thank the faculty for eight really great years, both in biology and in the medical school. They have risen to every challenge, including COVID-19, and they share the vision of what we can be if we come together. The future is really bright for the life sciences at Brown and the integrated academic health system.”

About Dr. Jack A. Elias

Over the course of his career, in both the clinic and the lab, Elias has taken on such difficult lung ailments as asthma, pneumonia, pulmonary fibrosis and the effects of smoking. Elias has been consistently funded by the National Institutes of Health (NIH), and has earned funding from industry and private foundations.

Elias networking
Dr. Elias meets with a Warren Alpert Medical School student during a BioMed event in 2015.

Elias continues to be actively engaged in research, and during the past two years has co-founded two biomedical companies based on his lab’s research, Elkurt Therapeutics and Ocean Biomedical. He has published more than 250 peer-reviewed research papers, holds several patents, and has received numerous prestigious honors and awards. He is a member of the National Academy of Medicine, serves on the Council of Councils of the NIH, and served on the NIH’s advisory council of the National Heart, Blood and Lung Institute (2009-2012), and as president of the Association of American Physicians (2010-2011). Elias has also trained scores of young researchers.

In addition to his significant work as a physician-scientist and educator, Elias has extensive administrative experience both in clinical and academic settings. He has directed outpatient clinics and intensive care programs and other clinical services, and served on many key administrative and academic committees.

Prior to arriving at Brown, he served as chair of medicine and physician-in-chief at Yale New Haven, beginning in 2006. Elias earned his bachelor’s degree and his M.D. at the University of Pennsylvania.